NYSE:NNVC

Nanoviricides Stock Insider Trading

Healthcare > Biotechnology

Buy NNVC

*Your capital is at risk

$1.31

-0.0100 (-0.758%)

At Close: Jun 23, 2026

NanoViricides Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 18.35M and sold 1.63M NNVC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	18.35M shares
● Sell	1.63M shares
90% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 12, 2016 Buy	Common Stock, par value $0.001 per share A-Award	Boniuk Milton Director	Director	34 043 Value: $40.2K
Feb 12, 2016 Buy	Common Stock, par value $0.001 per share A-Award	Boniuk Milton Director	Director	34 043 Value: $40.2K
Feb 10, 2016 Buy	Common Stock, par value $0.001 per share A-Award	Boniuk Milton Director	Director	9 000 Value: $12.2K
Feb 10, 2016 Buy	Common Stock, par value $0.001 per share A-Award	Boniuk Milton Director	Director	9 000 Value: $12.2K
Feb 08, 2016 Buy	Common Stock, par value $0.001 per share A-Award	Boniuk Milton Director	Director	9 000 Value: $12.6K
Feb 08, 2016 Buy	Common Stock, par value $0.001 per share A-Award	Boniuk Milton Director	Director	9 000 Value: $12.6K
Nov 11, 2015 Buy	Common Stock, par value $0.001 per share P-Purchase	Boniuk Milton Director	Director	25 000 Value: $30.0K
Nov 11, 2015 Buy	Common Stock, par value $0.001 per share P-Purchase	Boniuk Milton Director	Director	25 000 Value: $30.0K
Oct 22, 2015 Buy	Common Stock, par value $0.001 per share P-Purchase	Boniuk Milton Director	Director	14 640 Value: $19.0K
Oct 22, 2015 Buy	Common Stock, par value $0.001 per share P-Purchase	Boniuk Milton Director	Director	14 640 Value: $19.0K
Oct 21, 2015 Buy	Common Stock, par value $0.001 per share P-Purchase	Boniuk Milton Director	Director	5 202 Value: $7K
Oct 21, 2015 Buy	Common Stock, par value $0.001 per share P-Purchase	Boniuk Milton Director	Director	5 202 Value: $7K
Oct 19, 2015 Buy	Common Stock, par value $0.001 per share P-Purchase	Boniuk Milton Director	Director	2 958 Value: $4K
Oct 19, 2015 Buy	Common Stock, par value $0.001 per share P-Purchase	Boniuk Milton Director	Director	2 958 Value: $4K
Oct 15, 2015 Buy	Common Stock, par value $0.001 per share P-Purchase	Boniuk Milton Director	Director	2 200 Value: $3K
Oct 15, 2015 Buy	Common Stock, par value $0.001 per share P-Purchase	Boniuk Milton Director	Director	2 200 Value: $3K
Sep 22, 2015 Buy	Common Stock, par value $0.001 per share M-Exempt	Diwan Anil President	CEO / President	208 771 Value: $73.1K
Sep 22, 2015 Sell	Common Stock, par value $0.001 per share F-InKind	Diwan Anil President	CEO / President	76 944 Value: $100.0K
Sep 22, 2015 Buy	Common Stock Options M-Exempt	Diwan Anil President	CEO / President	285 715 Value: $100.0K
Sep 22, 2015 Buy	Common Stock, par value $0.001 per share M-Exempt	Seymour Eugene Chief Executive Officer	CEO / President	104 384 Value: $36.5K
Sep 22, 2015 Sell	Common Stock, par value $0.001 per share F-InKind	Seymour Eugene Chief Executive Officer	CEO / President	38 472 Value: $50.0K
Sep 22, 2015 Sell	Common Stock, par value $0.001 per share F-InKind	Seymour Eugene Chief Executive Officer	CEO / President	38 472 Value: $50.0K
Sep 22, 2015 Buy	Common Stock, par value $0.001 per share M-Exempt	Seymour Eugene Chief Executive Officer	CEO / President	104 384 Value: $36.5K
Sep 22, 2015 Buy	Common Stock Options M-Exempt	Diwan Anil President	CEO / President	285 715 Value: $100.0K
Sep 22, 2015 Sell	Common Stock, par value $0.001 per share F-InKind	Diwan Anil President	CEO / President	76 944 Value: $100.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NANOVIRICIDES, INC

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular...

Read Full Profile Here